1,730
Views
38
CrossRef citations to date
0
Altmetric
Review Articles

Growth hormone, inflammation and aging

&
Article: 17293 | Received 31 Jan 2012, Accepted 01 Mar 2012, Published online: 04 Apr 2012

References

  • Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. 1993; 14120-39.
  • Veldhuis JD. Aging and hormones of the hypothalamo-pituitary axis: gonadotropic axis in men and somatotropic axes in men and women. 2008; 73189-208. 10.3402/pba.v2i0.17293.
  • Brown-Borg HM, Borg KE, Meliska CJ, Bartke A. Dwarf mice and the ageing process. 1996; 38466043310.3402/pba.v2i0.17293.
  • Flurkey K, Papaconstantinou J, Miller RA, Harrison DE. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. 2001; 98126736-41. 10.3402/pba.v2i0.17293.
  • Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A, Kopchick JJ. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. 2003; 14493799-810. 10.3402/pba.v2i0.17293.
  • Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). 1997; 942413215-20. 10.3402/pba.v2i0.17293.
  • Ikeno Y, Bronson RT, Hubbard GB, Lee S, Bartke A. Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity. 2003; 584291-6. 10.3402/pba.v2i0.17293.
  • Ikeno Y, Hubbard GB, Lee S, Cortez LA, Lew CM, Webb CR et al. Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice. 2009; 645522-9. 10.3402/pba.v2i0.17293.
  • Menezes Oliveira JL, Marques-Santos C, Barreto-Filho JA, Ximenes Filho R, de Oliveira Britto AV, Oliveira Souza AH et al. Lack of evidence of premature atherosclerosis in untreated severe isolated growth hormone (GH) deficiency due to a GH-releasing hormone receptor mutation. 2006; 9162093-9. 10.3402/pba.v2i0.17293.
  • Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, Cheng CW et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. 2011; 37070ra1310.3402/pba.v2i0.17293.
  • van Heemst D, Beekman M, Mooijaart SP, Heijmans BT, Brandt BW, Zwaan BJ et al. Reduced insulin/IGF-1 signalling and human longevity. 2005; 4279-85. 10.3402/pba.v2i0.17293.
  • Suh Y, Atzmon G, Cho MO, Hwang D, Liu B, Leahy DJ et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians. 2008; 10593438-42. 10.3402/pba.v2i0.17293.
  • Bartke A. Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. 2003; 784210-6. 10.3402/pba.v2i0.17293.
  • Finch CE, Crimmins EM. Inflammatory exposure and historical changes in human life-spans. 2004; 30556911736-9. 10.3402/pba.v2i0.17293.
  • De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. 2005; 579102035-9. 10.3402/pba.v2i0.17293.
  • Deepak D, Daousi C, Javadpour M, Clark D, Perry Y, Pinkney J et al. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency. 2010; 203220-5. 10.3402/pba.v2i0.17293.
  • Jaworek J, Leja-Szpak A, Dembinski A, Tomaszewska R, Szklarczyk J, Kot M et al. Involvement of sensory nerves in the protective effect of growth hormone on acute pancreatitis. 2009; 196517-22. 10.3402/pba.v2i0.17293.
  • Yi C, Cao Y, Mao SH, Liu H, Ji LL, Xu SY et al. Recombinant human growth hormone improves survival and protects against acute lung injury in murine Staphylococcus aureus sepsis. 2009; 5812855-62. 10.3402/pba.v2i0.17293.
  • Frost RA, Pereyra E, Lang CH. Ethyl pyruvate preserves IGF-I sensitivity toward mTOR substrates and protein synthesis in C2C12 myotubes. 2011; 1521151-63. 10.3402/pba.v2i0.17293.
  • Wang Z, Masternak MM, Al-Regaiey KA, Bartke A. Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice. 2007; 14862845-53. 10.3402/pba.v2i0.17293.
  • Coschigano KT, Wetzel AN, Obichere N, Sharma A, Lee S, Rasch R et al. Identification of differentially expressed genes in the kidneys of growth hormone transgenic mice. 2010; 205345-55. 10.3402/pba.v2i0.17293.
  • Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E et al. Inflamm-aging. An evolutionary perspective on immunosenescence. 2000; 908: 244-54. 10.3402/pba.v2i0.17293.
  • Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. 2001; 83131-6. 10.3402/pba.v2i0.17293.
  • Pahlavani MA. Caloric restriction and immunosenescence: a current perspective. 2000; 5: D580-7. 10.3402/pba.v2i0.17293.
  • Pahlavani MA, Vargas DM. Influence of aging and caloric restriction on activation of Ras/MAPK, calcineurin, and CaMK-IV activities in rat T cells. 2000; 2232163-9. 10.3402/pba.v2i0.17293.
  • Pahlavani MA. Influence of caloric restriction on aging immune system. 2004; 8138-47.
  • Fernandes G, Venkatraman JT, Turturro A, Attwood VG, Hart RW. Effect of food restriction on life span and immune functions in long-lived Fischer-344 x Brown Norway F1 rats. 1997; 17185-95. 10.3402/pba.v2i0.17293.
  • Bastard J-P, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. 2006; 1714-12.
  • Olefsky JM, Glass CK. Macrophages, Inflammation, and Insulin Resistance. 2010; 72: 219-246. 10.3402/pba.v2i0.17293.
  • Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. 2004; 8962548-56. 10.3402/pba.v2i0.17293.
  • Coppack, SW. Adipose tissue changes in obesity. . 2005; 33(5): 1049–52..
  • Fantuzzi G. Adipose tissue, adipokines, and inflammation. 2005; 1155911-9. 10.3402/pba.v2i0.17293.
  • Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. 2001; 8651930-5. 10.3402/pba.v2i0.17293.
  • Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. 2010; 11: 11-8. 10.3402/pba.v2i0.17293.
  • Sashinami H, Nakane A. Adiponectin is required for enhancement of CCL2 expression in adipose tissue during Listeria monocytogenes infection. 2010; 502170-4. 10.3402/pba.v2i0.17293.
  • Cousin B, Munoz O, Andre M, Fontanilles AM, Dani C, Cousin JL et al. A role for preadipocytes as macrophage-like cells. 1999; 132305-12.
  • Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Anthony W, Ferrante J. Obesity is associated with macrophage accumulation in adipose tissue. 2003; 112: 1796-808.
  • Hooper PL. Inflammation, heat shock proteins, and type 2 diabetes. 2009; 142113-5. 10.3402/pba.v2i0.17293.
  • Spaulding CC, Walford RL, Effros RB. Calorie restriction inhibits the age-related dysregulation of the cytokines TNF-alpha and IL-6 in C3B10RF1 mice. 1997; 931–387-94. 10.3402/pba.v2i0.17293.
  • Spaulding CC, Walford RL, Effros RB. The accumulation of non-replicative, non-functional, senescent T cells with age is avoided in calorically restricted mice by an enhancement of T cell apoptosis. 1997; 931–325-33. 10.3402/pba.v2i0.17293.
  • Oeppen J, Vaupel JW. Demography. Broken limits to life expectancy. 2002; 29655701029-31. 10.3402/pba.v2i0.17293.
  • Crimmins EM, Finch CE. Infection, inflammation, height, and longevity. 2006; 1032498-503. 10.3402/pba.v2i0.17293.
  • Georges JL, Rupprecht HJ, Blankenberg S, Poirier O, Bickel C, Hafner G et al. Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. 2003; 925515-21. 10.3402/pba.v2i0.17293.
  • Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. . 2004; 109(21 Suppl1)II2-10.
  • Murphy WJ, Durum SK, Longo DL. Role of neuroendocrine hormones in murine T cell development. Growth hormone exerts thymopoietic effects in vivo. 1992; 149123851-7.
  • Dumont F, Robert F, Bischoff P. T and B lymphocytes in pituitary dwarf Snell-Bagg mice. 1979; 38123-31.
  • Duquesnoy RJ. Immunodeficiency of the thymus-dependent system of the Ames dwarf mouse. 1972; 10861578-90.
  • Fabris N, Pierpaoli W, Sorkin E. Hormones and the immunological capacity. IV. Restorative effects of developmental hormones or of lymphocytes on the immunodeficiency syndrome of the dwarf mouse. 1971; 92227-40.
  • Baroni CD, Fabris N, Bertoli G. Effects of hormones on development and function of lymphoid tissues. Synergistic action of thyroxin and somatotropic hormone in pituitary dwarf mice. 1969; 172303-14.
  • Cross RJ, Bryson JS, Roszman TL. Immunologic disparity in the hypopituitary dwarf mouse. 1992; 14851347-52.
  • Schneider GB. Immunological competence in Snell-Bagg pituitary dwarf mice: response to the contact-sensitizing agent oxazolone. 1976; 1453371-93. 10.3402/pba.v2i0.17293.
  • Dhahbi J, Li X, Tran T, Masternak MM, Bartke A. Circulating blood leukocyte gene expression profiles: effects of the Ames dwarf mutation on pathways related to immunity and inflammation. 2007; 428772-88. 10.3402/pba.v2i0.17293.
  • Montecino-Rodriguez E, Clark R, Johnson A, Collins L, Dorshkind K. Defective B cell development in Snell dwarf (dw/dw) mice can be corrected by thyroxine treatment. 1996; 15783334-40.
  • Esquifino AI, Villanua MA, Szary A, Yau J, Bartke A. Ectopic pituitary transplants restore immunocompetence in Ames dwarf mice. 1991; 125167-72.
  • Masternak MM, Panici JA, Wang F, Wang Z, Spong A. The effects of growth hormone (GH) treatment on GH and insulin/IGF-1 signaling in long-lived Ames dwarf mice. 2010; 65124-30. 10.3402/pba.v2i0.17293.
  • Louis A, Bartke A, Masternak MM. Effects of growth hormone and thyroxine replacement therapy on insulin signaling in Ames dwarf mice. 2010; 654344-52. 10.3402/pba.v2i0.17293.
  • Wang Z, Al-Regaiey KA, Masternak MM, Bartke A. Adipocytokines and lipid levels in Ames dwarf and calorie-restricted mice. 2006; 614323-31. 10.3402/pba.v2i0.17293.
  • Masternak MM, Panici JA, Bonkowski MS, Hughes LF, Bartke A. Insulin sensitivity as a key mediator of growth hormone actions on longevity. 2009; 645516-21. 10.3402/pba.v2i0.17293.
  • Bonkowski MS, Dominici FP, Arum O, Rocha JS, Al Regaiey KA, Westbrook R et al. Disruption of growth hormone receptor prevents calorie restriction from improving insulin action and longevity. 2009; 42e456710.3402/pba.v2i0.17293.
  • Al-Regaiey KA, Masternak MM, Bonkowski M, Sun L, Bartke A. Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor i/insulin signaling and caloric restriction. 2005; 1462851-60. 10.3402/pba.v2i0.17293.
  • Bonkowski MS, Pamenter RW, Rocha JS, Masternak MM, Panici JA, Bartke A. Long-lived growth hormone receptor knockout mice show a delay in age-related changes of body composition and bone characteristics. 2006; 616562-7. 10.3402/pba.v2i0.17293.
  • Masternak MM, Bartke A, Wang F, Spong A, Gesing A, Fang Y et al. Metabolic effects of intra-abdominal fat in GHRKO mice. 2012; 11173-81. 10.3402/pba.v2i0.17293.
  • Bonkowski MS, Rocha JS, Masternak MM, Al Regaiey KA, Bartke A. Targeted disruption of growth hormone receptor interferes with the beneficial actions of calorie restriction. 2006; 103207901-5. 10.3402/pba.v2i0.17293.